<DOC>
	<DOC>NCT00775697</DOC>
	<brief_summary>In this study children with recurrent wheezing (&gt;/= 2 episodes in the last 6 months)and aged less than 2 years will be enrolled as outpatients. They will undergo lung function evaluation by Rint and by assessment of the flow curves at baseline and after 4 weeks of treatment with Montelukast 4 mg/day. Symptom dairies will be filled by parents during the study period.</brief_summary>
	<brief_title>Montelukast in Children With Wheezing</brief_title>
	<detailed_description>Patients aged less than 2 years with recurrent wheezing. At visit 1 patients with symptoms will be enrolled and the study explained. They will return home with bronchodilator therapy. Within 1 week they will return for visit 2 to start a run-in period with bronchodilators prn and they will fill dairies with symptoms and drug use. Skin prick test will be evaluated at that time. At visit 3 after 1 week of the run-in period they will start therapy with Montelukast 4 mg for 4 weeks, using bronchodilators prn and filling diaries. The final visit will be after four weeks with re-evaluation of the lung function</detailed_description>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<criteria>Age between 624 months Patients with recurrent wheezing (at least 2 episodes in the last 6 months) Patients with symptoms at enrollment Chronic respiratory diseases (cystic fibrosis, chronic lung disease) symptoms at visit 1 that require hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>wheezing</keyword>
	<keyword>children</keyword>
	<keyword>montelukast</keyword>
	<keyword>bronchodilators</keyword>
	<keyword>lung function</keyword>
	<keyword>Rint</keyword>
</DOC>